Z. Dominski et R. Kole, RESTORATION OF CORRECT SPLICING IN THALASSEMIC PREMESSENGER RNA BY ANTISENSE OLIGONUCLEOTIDES, Proceedings of the National Academy of Sciences of the United Statesof America, 90(18), 1993, pp. 8673-8677
Antisense 2'-O-methylribooligonucleotides were targeted against specif
ic sequence elements in mutated human beta-globin pre-mRNAs to restore
correct splicing of these RNAs in vitro. The following mutations of t
he beta-globin gene, A --> G at nt 110 of the first intron (beta110),
T --> G at nt 705 and C --> T at nt 654 of the second intron (IVS2(705
) and IVS2(654), respectively), which led to aberrant splicing of the
corresponding pre-mRNAs, were previously identified as the underlying
causes of beta-thalassemia. Aberrant splicing of beta110 pre-mRNA was
efficiently reversed by an oligonucleotide targeted against the branch
point sequence in the first intron of the pre-mRNA but not by an olig
onucleotide targeted against the aberrant 3' splice site. In both IVS2
(705) and IVS2(654) pre-mRNAs, correct splicing was restored by oligon
udeotides targeted against the aberrant 5' splice sites created by the
mutations in the second intron or against a cryptic 3' splice site lo
cated upstream and activated in the mutated background. These experime
nts represent an approach in which antisense oligonucleotides are used
to restore the function of a defective gene and not, as usual, to dow
n-regulate the expression of an undesirable gene.